JPWO2024248079A5 - - Google Patents
Info
- Publication number
- JPWO2024248079A5 JPWO2024248079A5 JP2025524867A JP2025524867A JPWO2024248079A5 JP WO2024248079 A5 JPWO2024248079 A5 JP WO2024248079A5 JP 2025524867 A JP2025524867 A JP 2025524867A JP 2025524867 A JP2025524867 A JP 2025524867A JP WO2024248079 A5 JPWO2024248079 A5 JP WO2024248079A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- solid formulation
- mirogabalin
- acceptable salt
- solid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023091991 | 2023-06-02 | ||
| PCT/JP2024/019828 WO2024248079A1 (ja) | 2023-06-02 | 2024-05-30 | ミロガバリンを含有する医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2024248079A1 JPWO2024248079A1 (https=) | 2024-12-05 |
| JPWO2024248079A5 true JPWO2024248079A5 (https=) | 2026-03-04 |
Family
ID=93658131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025524867A Pending JPWO2024248079A1 (https=) | 2023-06-02 | 2024-05-30 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPWO2024248079A1 (https=) |
| KR (1) | KR20260018020A (https=) |
| CN (1) | CN121218983A (https=) |
| TW (1) | TW202513048A (https=) |
| WO (1) | WO2024248079A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119732941B (zh) * | 2024-12-30 | 2026-04-28 | 上海博悦生物科技有限公司 | 含有苯磺酸美洛加巴林的药物组合物及其制备方法 |
| CN120531691B (zh) * | 2025-06-20 | 2026-04-28 | 苏州美诺医药科技有限公司 | 一种苯磺酸美洛加巴林固体药物组合物、制剂及其制备方法 |
| CN121221543A (zh) * | 2025-11-26 | 2025-12-30 | 华润双鹤利民药业（济南）有限公司 | 一种苯磺酸美洛加巴林口崩片制剂及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2657219B1 (en) | 2007-09-28 | 2014-12-10 | Daiichi Sankyo Company, Limited | Intermediate for producing bicyclic y-amino acid derivative |
| CN104334169B (zh) | 2013-04-04 | 2016-11-02 | 第一三共株式会社 | 包含氨基羧酸盐的固体组合物 |
| BR112017019918B1 (pt) | 2015-03-19 | 2023-11-07 | Daiichi Sankyo Company, Limited | Preparação sólida farmacêutica, e, método para produzir uma preparação sólida farmacêutica para estabilizar uma preparação sólida farmacêutica |
| BR112017019920B1 (pt) | 2015-03-19 | 2023-11-07 | Daiichi Sankyo Company, Limited | Preparação sólida farmacêutica, e, método para estabilização de uma preparação sólida farmacêutica |
| BR112021001008A2 (pt) | 2018-07-30 | 2021-04-20 | Daiichi Sankyo Company, Limited | comprimido de fármaco |
| ES3025936T3 (en) * | 2019-12-23 | 2025-06-10 | Daiichi Sankyo Co Ltd | Film-coated tablets having smooth surface |
| CN115803020A (zh) * | 2020-07-27 | 2023-03-14 | 第一三共株式会社 | 含有苯磺酸米洛巴林的口腔崩解片剂 |
-
2024
- 2024-05-30 JP JP2025524867A patent/JPWO2024248079A1/ja active Pending
- 2024-05-30 TW TW113119971A patent/TW202513048A/zh unknown
- 2024-05-30 WO PCT/JP2024/019828 patent/WO2024248079A1/ja not_active Ceased
- 2024-05-30 KR KR1020257037178A patent/KR20260018020A/ko active Pending
- 2024-05-30 CN CN202480035836.7A patent/CN121218983A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2024248079A5 (https=) | ||
| CN103735530A (zh) | 吡非尼酮与药物可接受的赋型剂的胶囊制剂 | |
| US9457094B2 (en) | Pharmaceutical composition containing fimasartan and hydrochlorothiazide | |
| RS65500B1 (sr) | Eutektičke formulacije ciklobenzaprin hidrohlorida i manitola | |
| JP2024063140A (ja) | トホグリフロジンを含有する固形製剤及びその製造方法 | |
| KR101923403B1 (ko) | 리마프로스트 또는 리마프로스트 알파엑스를 함유한 경구용 서방성 제제 조성물 | |
| JP7104039B2 (ja) | 医薬組成物 | |
| EP3773508A1 (en) | Pharmaceutical composition comprising brexpiprazole | |
| TR201918102A1 (tr) | Bi̇r polar çözücüden i̇zole edi̇lmi̇ş amorf dapagli̇flozi̇n i̇çeren kati farmasöti̇k kompozi̇syon | |
| TR202019592A2 (tr) | Amorf dapagliflozinin katı farmasötik formülasyonları | |
| CN108174596A (zh) | 包含8-[(3r)-3-氨基-1-哌啶基]-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-[4-甲基-2-喹唑啉基)甲基]-1h-嘌呤-2,6-二酮或其药学上可接受的盐的药物组合物 | |
| RU2698703C2 (ru) | Твердая фармацевтическая композиция, содержащая амлодипин и лозартан | |
| KR20200122114A (ko) | 피르페니돈 및 아세틸시스테인의 공융혼합물 및 이의 제조방법 | |
| CN102552920B (zh) | 一种含恩替卡韦的药物组合物及其制备方法 | |
| KR101048487B1 (ko) | 말레인산트리메부틴 서방정 | |
| KR102078691B1 (ko) | 피마살탄을 포함하는 고체 분산체 | |
| RU2834292C1 (ru) | Фармацевтические композиции c контролируемым высвобождением в форме монолитных матриксных таблеток, содержащие ребамипид, и способы для их приготовления | |
| WO2015198225A1 (en) | Oral pharmaceutical composition of tofacitinib | |
| US20120258171A1 (en) | Composition comprising fesoterodine and fiber | |
| CN119033757B (zh) | 一种恩格列净药物组合物及其制备方法 | |
| KR20110056071A (ko) | 올란자핀을 함유하는 확산정 조성물 및 이에 의해 형성된 정제 | |
| KR102235848B1 (ko) | 바레니클린 또는 이의 약학적으로 허용가능한 염의 지연 방출용 정제 | |
| JP2019210276A (ja) | 錠剤及びその製造方法 | |
| CN119318640A (zh) | 一种稳定的法莫替丁钙镁咀嚼片及其制备 | |
| EP4420658A1 (en) | A film coated tablet comprising empagliflozin |